Vascular CT Assessment of Structural Autograft and Allograft Healing
- Conditions
- Bone Tumors
- Interventions
- Device: Cone Beam CT Scan
- Registration Number
- NCT00594776
- Lead Sponsor
- University of Rochester
- Brief Summary
The purpose of this study is to determine the ability of a cone beam CT to measure bone healing.
- Detailed Description
The purpose of this study is to investigate quantitative vascular cone beam CT(CBCT) in a clinical pilot of patients that have received a structural allograft for bone cancer or a vascularized structural autograft for bone cancer or traumatic injury. Development of a minimally invasive, longitudinal outcome measure to quantify intramedullary vascular volume and cortical bone volume of structural allografts in patients is required to translate "revitalizing" structural allograft in clinical trials. Our novel vascular CBCT will be able to demonstrate the significant differences between vascularized fibular autografts vs. structural allografts in patients that will undergo structural grafting. These data will be used to devise a power calculation for a definitive clinical trial to evaluate the efficacy of the revitalizing allograft.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 8
- male or female
- all races will be included
- autograft or allograft of long bone as part of treatment for bone tumor
- pregnancy
- patients with a history of IV contrast reactions
- contraindication to use of epinephrine or diphenhydramine
- hypertyroidism or history of sensitivity to iodine
- kidney disease (abnormal urinalysis or calculaged GFR) or poor hydration due to poor intake or other causes
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1 Cone Beam CT Scan Patients who have received a structrual allograft or vascularized fibular autograft surgery to reconstruct their tibia, femur, ulna/radius or humerus for treatment of a bone tumor.
- Primary Outcome Measures
Name Time Method Change in intramedullary vascular volume and new bone growth based on CBCT 2, 8 & 18 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Rochester
🇺🇸Rochester, New York, United States